HIS
ANIK icon

Horizon Investment Services’s Anika Therapeutics ANIK Stock Holding History

Horizon Investment Services’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-35,125
Closed -$1.34M – 121
2013
Q4 		$1.34M Sell
35,125
-38,940
-53% -$1.2M 0.81% 49
2013
Q3 		$1.77M Buy
74,065
+16,775
+29% +$377K 1.21% 45
2013
Q2 		$974K Buy
+57,290
New +$826K 0.77% 49

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Horizon Investment Services's ANIK Position: Q1 2014 in Review

Horizon Investment Services sold out of Anika Therapeutics (ANIK) in Q1 2014, closing a stake of 35,125 shares — an estimated $1.34M sold.

Horizon Investment Services first reported a position in ANIK in Q2 2013 and held it in 3 quarters. The position peaked at $1.77M in Q3 2013. 153 funds tracked by Wall St. Rank hold ANIK as of Q1 2014.

  • Horizon Investment Services reported no remaining Anika Therapeutics position as of Q1 2014 after selling out during the quarter.
  • Horizon Investment Services sold 35,125 Anika Therapeutics shares in Q1 2014, an estimated $1.34M.
  • Horizon Investment Services first reported a position in Anika Therapeutics in Q2 2013 and held it in 3 quarters.
  • Horizon Investment Services's Anika Therapeutics position peaked at $1.77M in Q3 2013.
  • 153 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2014.

Based on Horizon Investment Services's 13F filing for Q1 2014, filed 14 May 2014.